ARE CHRONIC INFLAMMATION AND CKD-MBD RISK FACTORS OF MORTALITY IN HEMODIALYSIS PATIENTS?

被引：0
|
作者：
Sircuta, Alexandru [1 ]
Bob, Flaviu [1 ,2 ]
Chiodan, Milena [1 ]
Maralescu, Felix-Mihai [1 ]
Schiller, Adalbert [1 ,2 ]
Schiller, Oana-Marina [3 ]
Petrica, Ligia [1 ,2 ]
机构：
[1] Victor Babe Univ Med & Pharm, Div Nephrol, Timisoara, Romania
[2] Victor Babe Univ Med & Pharm, Ctr Mol Res Nephrol & Vasc Dis, Timisoara, Romania
[3] B Braun Avitum Dialysis Ctr, Timisoara, Romania
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO933
引用
收藏
页码：I677 / I678
页数：2
相关论文
共 50 条
  • [31] Importance of bone turnover for therapeutic decisions in patients with CKD-MBD
    Ott, Susan M.
    Malluche, Hartmut H.
    Jorgetti, Vanda
    Elder, Grahame J.
    KIDNEY INTERNATIONAL, 2021, 100 (03) : 502 - 505
  • [32] Update on the role of bone biopsy in the management of patients with CKD-MBD
    Evenepoel, P.
    Behets, G. J. S.
    Laurent, M. R.
    D'Haese, P. C.
    JOURNAL OF NEPHROLOGY, 2017, 30 (05) : 645 - 652
  • [33] SERUM SCLEROSTIN IS A NEW PLAYER IN THE CKD-MBD RELATED MORTALITY AND CARDIOVASCULAR EVENTS
    Kanbay, Mehmet
    Siriopol, Dimitrie
    Saglam, Mutlu
    Kurt, Yasemin G.
    Gok, Mahmut
    Cetinkaya, Hakki
    Karaman, Murat
    Unal, Hilmi U.
    Oguz, Yusuf
    Sari, Sebahattin
    Eyileten, Tayfun
    Vural, Abdulgaffar
    Covic, Adrian
    Yilmaz, Mahmut I.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 12 - 12
  • [34] Etelcalcetide Utilization, Dosing Titration, and Chronic Kidney Disease-Mineral and Bone Disease (CKD-MBD) Marker Responses in US Hemodialysis Patients
    Karaboyas, Angelo
    Muenz, Daniel
    Fuller, Douglas S.
    Desai, Pooja
    Lin, Tzu-Chieh
    Robinson, Bruce M.
    Rossetti, Sandro
    Pisoni, Ronald L.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (03) : 362 - 373
  • [35] Phosphorus and other aspects of CKD-MBD in the conservative management of chronic kidney disease
    Shah, Anuja
    PANMINERVA MEDICA, 2017, 59 (02) : 124 - 132
  • [36] DIETARY PHOSPHORUS RESTRICTION IN EARLY STAGES OF CHRONIC KIDNEY DISEASE IMPROVES RENAL FUNCTION, AND CONTROLS CKD-MBD AND CARDIOVASCULAR RISK FACTORS
    Saxena, Anita
    Gupta, Amit
    Kapoor, Vishwas
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S89 - S89
  • [37] TBX2 Is a CKD-MBD Causal Gene by Regulating Calcium Homeostasis and Inflammation
    Li Shen
    Susztak, Katalin
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [38] The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology
    Hruska, Keith A.
    Sugatani, Toshifumi
    Agapova, Olga
    Fang, Yifu
    BONE, 2017, 100 : 80 - 86
  • [39] Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)
    Komaba, Hirotaka
    Tanaka, Motoko
    Fukagawa, Masafumi
    INTERNAL MEDICINE, 2008, 47 (11) : 989 - 994
  • [40] ARTERIAL STIFFNESS AND CHRONIC KIDNEY DISEASE-MINERAL BONE DISORDER (CKD-MBD) IN HEMODIALYSED PATIENTS
    Bob, Flaviu
    Schiller, Adalbert
    Schiller, Oana
    Timar, Romulus
    Buzas, Roxana
    Bujor, Georgeta
    Grosu, Iulia Dana
    Timar, Bogdan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
12345